Healthtronics, Inc. - Statement of Changes in Beneficial Ownership (4)
March 12 2008 - 5:07PM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
See
Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Expires:
January 31, 2008
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public
Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
GOOLSBY ROSS A
|
2. Issuer Name
and
Ticker or Trading Symbol
HEALTHTRONICS, INC.
[
HTRN
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director
_____ 10% Owner
__
X
__ Officer (give title below)
_____ Other (specify below)
CFO & Sr. Vice President
|
(Last)
(First)
(Middle)
1301 CAPITAL OF TEXAS HWY, SUITE 200B
|
3. Date of Earliest Transaction
(MM/DD/YYYY)
3/10/2008
|
(Street)
AUSTIN, TX 78746
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_
X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security
(Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code
(Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Common Stock
|
3/10/2008
|
|
A
|
|
124775
|
A
(1)
(2)
|
$0
|
137275
|
D
|
|
Table II - Derivative Securities Beneficially Owned (
e.g.
, puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 3)
|
2. Conversion or Exercise Price of Derivative Security
|
3. Trans. Date
|
3A. Deemed Execution Date, if any
|
4. Trans. Code
(Instr. 8)
|
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
6. Date Exercisable and Expiration Date
|
7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
|
8. Price of Derivative Security
(Instr. 5)
|
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)
|
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)
|
11. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
(A)
|
(D)
|
Date Exercisable
|
Expiration Date
|
Title
|
Amount or Number of Shares
|
Explanation of Responses:
|
(
1)
|
On March 10, 2008, Mr. Goolsby was awarded a restricted stock grant of 124,775 shares of common stock of HealthTronics,
Inc. (the "Company") under the Company's 2004 Equity Incentive Plan. The restricted stock award vests as follows: (a)
43,672 shares vest one-fourth (10,918 shares) on each of the first four anniversaries of the date of grant, provided, that
vesting of such shares will be accelerated based on the achievement of the performance targets described in (2) below within
the first two years after the date of grant (in order starting with the first one-fourth unvested tranche next scheduled to
vest) and (b) 81,103 shares vest as described in (2) below.
|
(
2)
|
81,103 shares vest based on the achievement of the following performance targets (shares that have not vested upon the
tenth anniversary of the grant date will be forfeited). If the closing price of Company common stock on any trading day
after the grant date equals or exceeds the following percentage of the closing price of Company common stock on the grant
date, then the following percentage of shares will vest: 115%, 25% of shares vest; 130%, 50% of shares vest; 145%, 75% of
shares vest; and 160%, 100% of shares vest.
|
Reporting Owners
|
Reporting Owner Name / Address
|
Relationships
|
Director
|
10% Owner
|
Officer
|
Other
|
GOOLSBY ROSS A
1301 CAPITAL OF TEXAS HWY
SUITE 200B
AUSTIN, TX 78746
|
|
|
CFO & Sr. Vice President
|
|
Signatures
|
/s/ Ross Goolsby
|
|
3/12/2008
|
**
Signature of Reporting Person
|
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
|
*
|
If the form is filed by more than one reporting person,
see
Instruction 4(b)(v).
|
**
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
Note:
|
File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure.
|
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
|
Htetf (MM) (NASDAQ:HTRN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Htetf (MM) (NASDAQ:HTRN)
Historical Stock Chart
From Sep 2023 to Sep 2024